EXPLORING ADVANCES IN LIVER MEDICINE: INSIGHTS FROM THE EXPERTS

Featuring: Sean W. P. Koppe, MD, Laura M. Kulik, MD, Andres Duarte, MD, Sarang B. Thaker, MD and Amanda C. Cheung, MD

Episode Summary

In this episode of Better Edge, Sean W. P. Koppe, MD, moderates a panel of hepatologist, featuring Laura M. Kulik, MD, Andres Duarte, MD, Sarang B. Thaker, MD and Amanda C. Cheung, MD, as they discuss recent advances and challenges in liver research. The conversation addresses such key issues as the timing of immunotherapy in relation to transplants, the role of albumin management and the implications of these factors on patient outcomes. This discussion offers valuable insights to fellow researchers and clinicians navigating the complexities of liver medicine.

The panel includes: 
Research discussed: 
Physicians who listen to this podcast may claim continuing medical education credit after listening to an episode of this program.

Information Regarding CME Accreditation
Target Audience
Specialties - Gastroenterology, Hepatology
​
Learning Objectives
At the conclusion of this activity, participants will be able to:
  1. Discuss the latest clinical advances and complex cases in the various Northwestern Memorial Hospital departments.
  2. Identify the latest research interest and initiatives of NMH physicians.
  3. Disseminate evidence-based patient care into practice.
Accreditation
The Northwestern University Feinberg School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
​
Credit Designation Statement
The Northwestern University Feinberg School of Medicine designates this enduring activity for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credits
AMA PRA Category 1 Credits™ (0.50 hours), Non-Physician Attendance (0.50 hours)

Disclosure information:
 
Speakers:
Amanda Cheung, MD, has no relevant financial relationships with any ineligible companies to disclose. Andres Duarte-Rojo, MD, states he receives research support from Echosens. Sean Koppe, MD, states he is on the speakers bureau for Gilead and Intercept. Laura Kulik, MD, states she is an advisor for Eisai, Inc., AstraZeneca, and Exelixis, the relationship with Exelixis has ended; she is on an advisory committee for Genentech, Inc., AstraZeneca, and FujiFilm; receives consulting fees from Genentech; she is on the speakers bureau for AstraZeneca; she is also an independent contractor for HCC Target and Glycotest, the relationship with HCC Target and Glycotest has ended. Sarang B. Thaker, MD, has not relevant financial relationships with any ineligible companies to disclose.
 
Course Director and planning committee:
Dr. Babak Jahromi, MD states he is a PI for IRRAS; also received honoraria from Penumbra but that relationship has ended.
 
Jasmine Sinha, MD has no relevant financial relationships with any ineligible companies to disclose.
 
All the relevant financial relationships for these individuals have been mitigated.
 
FSM’s CME Leadership, Review Committee, and Staff have no relevant financial relationships with ineligible companies to disclose.
Sean W. P. Koppe, MD, Associate Professor of Gastroenterology and Hepatology at Northwestern Medicine.

Refer a Patient

Northwestern Medicine welcomes the opportunity to collaborate with you in caring for your patients. ​

You May Also Like